The inhibitory activity of ginsenoside Rp4 in adenosine diphosphate-induced platelet aggregation

G-Rp4 significantly inhibited ADP-induced platelet aggregation and this is mediated via modulating the intracellular signaling molecules. These results indicate that G-Rp4 could be a potential candidate as a therapeutic agent against platelet-related cardiovascular diseases.